Wird geladen...
Emerging Variants of Castration-Resistant Prostate Cancer
Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...
Gespeichert in:
| Veröffentlicht in: | Curr Oncol Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/ https://ncbi.nlm.nih.gov/pubmed/28361223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|